NCT05199688 Phase 3
Recruiting
A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)
Enrollment
8 pts
Location
United States, Argen...
Sponsor
Hoffmann-La Roche
NCT05966467
Recruiting
Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
Enrollment
122 pts
Location
United States, Argen...
Sponsor
Alexion Pharmaceuticals, Inc.